Pylarify (Piflufolastat F18)
- Medicine Name: Pylarify
- Generic Name: Piflufolastat F18
- Dosage Form & Strength: Injection: a multiple-dose vial containing 37 MBq/mL to 2,960 MBq/mL (1 mCi/mL to 80 mCi/mL)
- Manufactured By: Progenics Pharmaceuticals, Inc.
Medical Uses: Pylarify is a radioactive diagnostic agent used for positron emission tomography (PET) of prostate-specific membrane antigen (PSMA) positive lesions in males with prostate cancer:
with suspected metastasis who are recipients for initial definitive therapy.
with suspected recurrence based on elevated serum prostatespecific antigen (PSA) level
Recommended Dosage: Pylarify is a radioactive medication. Only authorized individuals qualified by training and experience should receive,use and administer this medicinal product. Handle this drug with appropriate safety measures to scale down radiation exposure during administration. Use waterproof gloves and and useful radiation shielding including syringe shields, when preparing and handling this injection.
The recommended amount of radioactivity to be used for PET imaging is 333 MBq (9 mCi) with an acceptable range of 296 to 370 MBq (8 to 10 mCi) given as a single bolus intravenous injection. Initiate imaging around 60 minutes after the administration of Pylarify. Patient should void promptly before starting imaging. Start image acquisition from mid-thigh and proceed to the skull vertex.
- Patient should drink water to ensure adequate hydration before administering the f18 pylarify and continue drinking and voiding frequently for initial some hours after administration to scale down radiation exposure.
- Imaging with Pylarify may be responsible for imaging Interpretation errors. A negative image does not rule out the existence of prostate cancer and a positive image does not confirm the existence of prostate cancer.
- Patients taking treatment with Pylarify need to monitored for hypersensitivity reactions, mainly those with a history of allergic reactions to other medicinal products and food. It is advisable to always have experienced staff and resuscitation equipment available.
- Diagnostic radiopharmaceuticals, including Piflufolastat F18, expose patients to radiation. The radiation exposure is linked with a dose-dependent greater risk of cancer. Ensure precise handling and preperation methods to protect patients and health workers from unintentional radiation exposure.
- Use of Piflufolastat F18 is not recommended in females. There is no deets on the existence of this medicine in human milk, the influence of the breastfed infant, or the influence on the milk production.
What documents are required to import PYLARIFY to India?
PYLARIFY (piflufolastat f 18) injection can be imported by patients or government hospitals on behalf of patients.
The following documentation is required to import the product:
- Valid prescription from a qualified doctor.
- Patient’s diagnostic reports.
- Patient’s Identity Proof (issued by the Government of India).
How is the order confirmed?
The order will be confirmed only after the receipt of:
- Valid prescription from a doctor.
- Import permit if applicable.
Is PYLARIFY available in India?
PYLARIFY (piflufolastat f18 injection) is a prescription pharmaceutical drug that legally requires a medical prescription to be dispensed. Urgent Meds helps import cancer medicines on the named patient supply (NPS). Urgent Meds is the facilitator providing input on:
- Availability of Pylarify in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune, etc.).
- Medicine Price.
- Finding genuine and reliable sources from Canada, Europe, USA, and Australia.
- Ensuring 100% transparency.
PYLARIFY can be made available to patients, doctors, and hospitals in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, Pune, and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and, if required, an import permit.
Urgent Meds can facilitate the supply of PYLARIFY (prescription medicines) to all locations in the world and in India after fulfilling the legal requirements (if applicable).
Please contact +1-647-818-4196 or write to us at info@urgentmeds.in for Pylarify price in India.
We guarantee quality and delivery anywhere in the world as per the buyer’s requirements
Urgent Meds is able to source PYLARIFY (Cancer Treatment Medicines) from across the globe and has the ability to supply. Urgent Meds offers its customers worldwide access to the best available treatment.
Urgent Meds is able to dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the patient’s address only from New Delhi, India.
What is the Generic Name for the trade name drug Pylarify®?
Piflufolastat F18 is the Generic Name for the trade name drug Pylarify®.
What is the Manufacturer’s Name of Pylarify®?
Pylarify® is manufactured by Progenics Pharmaceuticals, Inc.
Is Pylarify® approved by the FDA?
Yes, Pylarify® is approved by the FDA. Date of first/initial approval: May 26, 2021.
Where can I get Pylarify® at the best price in India?
To get the best Pylarify® price in India, kindly contact Urgent Meds (a WHO GDP & ISO 9001:2008 certified company). For Pylarify®, a valid medical prescription is required from your treating physician.
What is the dosage and form of Pylarify® supplied?
Pylarify® is supplied as Injection: clear, colorless solution in a multiple-dose vial containing 37 MBq/mL to 2,960 MBq/mL (1 mCi/mL to 80 mCi/mL) of piflufolastat F 18 at calibration date and time for intravenous administration.
What are the most common side effects with Pylarify®?
The most common side effects with Pylarify® include: fatigue, headaches, and dysgeusia.
How much does Pylarify® cost in India?
The Pylarify® cost in India is less and can vary. In order to procure this medication authentically, you can call or WhatsApp +1-647-818-4196 or send mail to info@urgentmeds.in.
What are the storage conditions of Pylarify®?
Store Pylarify® at a temperature of 20°C to 25°C (68°F to 77°F). This medicinal product does not contain any preservative. Store it in the original container with radiation shielding. Use the medicine within 10 hours from the time of the end of synthesis.
Is it safe to buy Pylarify® online in India?
Yes, you can buy Pylarify® in India online at the best price from Urgent Meds if Pylarify® has not been approved or is not available in your country.
Contact Patient Support
If you have any questions or need any help, contact our Patient Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
Disclaimer
All Trademarks and Brands that appear on the website belong to their respective owners and indianpharmanetwork does not lay any claim on them we only provide Information.